Dr Luigi Aurisicchio will present compelling data on the increased overall survival in Lymphoma canine patients as a result of combining Chemotherapy with TK004, our Ad/DNA-EGT based cancer vaccine targeting canine telomerase. For the first time, Luigi Aurisicchio will present the data of the US clinical trial conducted by Dr JA Impellizeri, VOS.

The meeting is a great opportunity to learn what is going on in Veterinary Oncology and Comparative Medicine.